Compositions Comprising NAD+ and Associated Methods of Treatment

Abstract: a composition is disclosed. the composition comprises an anesthetic and nad+. in some embodiments, the anesthetic is lidocaine. in some embodiments, the composition comprises about 5 mg/ml lidocaine to about 20 mg/ml lidocaine. in some embodiments, the composition comprises about 20 mg/ml lidocaine. in some embodiments, the composition comprises about 50 mg/ml to about 500 mg/ml nad+. in some embodiments, the composition comprises about 200 mg/ml nad+. in some embodiments the combination comprises an anesthetic, nad+, and an nmda receptor antagonist. in some embodiments, the nmda receptor antagonist is ketamine. in some embodiments, the composition comprises about 10 mg/ml ketamine to about 200 mg/ml ketamine. in some embodiments, the composition comprises about 50 mg/ml ketamine, in some embodiments, the combination comprises an anesthetic, nad+, an nmda receptor antagonist, and a corticosteroid. in some embodiments, the corticosteroid is dexamethasone. in some embodiments, the composition comprises about 0.5 mg/ml dexamethasone to about 3 mg/ml dexamethasone.

Inventor(s): David Henry Workman

CPC Classification: A61K31/7084 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250177430